Find information on colon, rectal, and stomach cancer support groups and advocacy organizations. Please see Important Safety Information and full Prescribing Information.

Indications LONSURF is indicated as a single agent or in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer previously treated with …

LONSURF is indicated as a single agent or in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer previously treated with fluoropyrimidine-, …

LONSURF is indicated as a single agent or in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer previously treated with fluoropyrimidine‑, …

Hi. My oncologist suggested I start on the Lonsurf regimen in a few weeks. Been reading the posts here and it looks like Longsurf only works for 10-12% of patients who take it. Some get …

Aug 24, 2025 · Lonsurf is a cancer medicine taken by mouth to treat some types of advanced digestive system cancers, specifically metastatic colorectal cancer and gastric (stomach) …

For most patients with colorectal cancer, LONSURF may be prescribed to be used with bevacizumab. Bevacizumab is given as an infusion once every 2 weeks (on Days 1 and 15 of …

Of the 1114 patients with metastatic colorectal cancer or gastric cancer who received single agent LONSURF in clinical studies, 45% were 65 years of age or over, and 11% were 75 and over.

Personalized services for patients, caregivers, and healthcare professionals through their treatment journeys including access, patient affordability assistance, and how to enroll with …

How does trifluridine and tipiracil (Lonsurf®) work? Trifluridine is designed to kill or slow the growth of colon cancer cells. Tipiracil slows down the body’s ability to break down trifluridine, …